Literature DB >> 23650080

Serological cross-reactivity between human polyomaviruses.

Ugo Moens1, Marijke Van Ghelue, Xiaobo Song, Bernhard Ehlers.   

Abstract

Until 2006, BKPyV and JCPyV were the only known human polyomaviruses. A third polyomavirus, simian virus 40 whose natural host is the macaque was accidently introduced into man because of contaminated poliovirus vaccines, although there is epidemiological evidence that SV40 may be transmitted between man independently from contaminated vaccines. Since 2007, 10 new human polyomaviruses have been identified: KIPyV, WUPyV, Merkel cell polyomavirus, trichodysplasia spinulosa-associated polyomavirus, and human polyomaviruses 6, 7, 9, 10, STL, and 12. Moreover, the DNA of the monkey lymphotropic polyomavirus has been amplified from human peripheral blood. Seroepidemiological studies frequently based on the presence of antibodies against the major capsid protein VP1 or virus-like particles indicate that most human adults have been exposed to many, if not all, human polyomaviruses. However, because of the high amino acid sequence identity between VP1 of some human polyomaviruses, cross-reactivity of antibodies is occasionally observed. In addition, human sera possess reactivity against VP1 of polyomaviruses from other species, suggesting serological cross-reaction with known or closely related, yet unidentified human polyomaviruses and/or the possibility of zoonotic transmission. Thus, current serological results should be interpreted with caution, and controls excluding cross-reactivity with other polyomaviruses are required.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23650080     DOI: 10.1002/rmv.1747

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  26 in total

1.  Development and Evaluation of a Broad Bead-Based Multiplex Immunoassay To Measure IgG Seroreactivity against Human Polyomaviruses.

Authors:  Hans L Zaaijer; Mariet C W Feltkamp; Sergio Kamminga; Els van der Meijden; Herman F Wunderink; Antoine Touzé
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

2.  Structure analysis of the major capsid proteins of human polyomaviruses 6 and 7 reveals an obstructed sialic acid binding site.

Authors:  Luisa J Ströh; Ursula Neu; Bärbel S Blaum; Michael H C Buch; Robert L Garcea; Thilo Stehle
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

3.  Seroepidemiology of Human Polyomaviruses in a US Population.

Authors:  Anala Gossai; Tim Waterboer; Heather H Nelson; Angelika Michel; Martina Willhauck-Fleckenstein; Shohreh F Farzan; Anne G Hoen; Brock C Christensen; Karl T Kelsey; Carmen J Marsit; Michael Pawlita; Margaret R Karagas
Journal:  Am J Epidemiol       Date:  2015-12-13       Impact factor: 4.897

4.  Crystallographic and glycan microarray analysis of human polyomavirus 9 VP1 identifies N-glycolyl neuraminic acid as a receptor candidate.

Authors:  Zaigham Mahmood Khan; Yan Liu; Ursula Neu; Michel Gilbert; Bernhard Ehlers; Ten Feizi; Thilo Stehle
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

Review 5.  The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer.

Authors:  Ugo Moens; Kashif Rasheed; Ibrahim Abdulsalam; Baldur Sveinbjørnsson
Journal:  Viruses       Date:  2015-04-10       Impact factor: 5.048

6.  Colorectal Carcinoma Affected Patients Are Significantly Poor Responders Against the Oncogenic JC Polyomavirus.

Authors:  Elena Torreggiani; Ilaria Bononi; Silvia Pietrobon; Elisa Mazzoni; Giovanni Guerra; Carlo Feo; Fernanda Martini; Mauro Tognon
Journal:  Front Immunol       Date:  2021-05-25       Impact factor: 7.561

7.  An antibody response to human polyomavirus 15-mer peptides is highly abundant in healthy human subjects.

Authors:  Lieven J Stuyver; Tobias Verbeke; Tom Van Loy; Ellen Van Gulck; Luc Tritsmans
Journal:  Virol J       Date:  2013-06-12       Impact factor: 4.099

8.  Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.

Authors:  Milda Norkiene; Jomante Stonyte; Danguole Ziogiene; Egle Mazeike; Kestutis Sasnauskas; Alma Gedvilaite
Journal:  BMC Biotechnol       Date:  2015-08-04       Impact factor: 2.563

9.  Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin.

Authors:  Els van der Meijden; Seweryn Bialasiewicz; Rebecca J Rockett; Sarah J Tozer; Theo P Sloots; Mariet C W Feltkamp
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

10.  Serological cross-reactivity between Merkel cell polyomavirus and two closely related chimpanzee polyomaviruses.

Authors:  Jérôme T J Nicol; Etienne Liais; Romain Potier; Elisa Mazzoni; Mauro Tognon; Pierre Coursaget; Antoine Touzé
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.